Skip to main content
Loading ResearchHub…
Cited by — Fulminant Secondary HLH Following EBV Reactivation in an Adult With Trisomy 21 After Teplizumab Treatment for Stage 2 Type 1 Diabetes | ResearchHub - ResearchHub